Competing interests: The authors have declared that no competing interests exist.
Competing interests: The authors have declared that no competing interests exist.
Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: Cathryn Lewis sits on the Myriad Neuroscience Scientific Advisory Board. The other authors declare no competing interests.
Competing interests: The authors have declared that no competing interests exist.
Competing interests: The authors have declared that no competing interests exist.
Competing interests: The authors have declared that no competing interests exist.
Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: [DG and HHT are employees and shareholders of Biogen]
Competing interests: The authors have declared that no competing interests exist.
Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: V.S. has consulted for Novo Nordisk and Sanofi and received honoraria from these companies (unrelated to the present study). He also has ongoing research collaboration with Bayer Ltd. (unrelated to the present study). A.P. is a member of the Pfizer Genetics Scientific Advisory Panel. The remaining authors declared no relevant competing interests.
Competing interests: The authors have declared that no competing interests exist.
Competing interests: The authors have declared that no competing interests exist.
Competing interests: The authors have declared that no competing interests exist.
Competing interests: The authors have declared that no competing interests exist.
Competing interests: The authors have declared that no competing interests exist.
Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: G.K.R. has been on principal investigator on research grants to Massachusetts General Hospital from Gilead Sciences, Citius Pharmaceuticals, Emergent Biosolutions, Pfizer and Leonard Meron Bioscience -all research support paid to the institution. E.S.D. has received research grant support from Gilead, Merck and ViiV and has been consultant for Abbvie, Gilead, Merck and Genentech. S.A.R. has been an investigator on research grants to the University of Pittsburgh from Gilead, Merck, and Bristol Myers Squibb and she has been a consultant to Novimab. M.D.R. is on the scientific advisory board for Cipherome and Goldfinch Bio. All other authors have no conflicts to disclose.